Search research articles
Contact Us
Filters
Showing results (91-100 of 238) with videos related to
Page
of 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2005
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
Jeffrey A Engelman, Pasi A Jänne, Craig Mermel, et al.
Pathologica
|
September 1, 1993
[The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]
E Philippe, B Faguer, A Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 17, 2012
FGFR1 amplification in squamous cell carcinoma of the lung
Rebecca S Heist, Mari Mino-Kenudson, Lecia V Sequist, et al.
Neuro-Oncology
|
July 15, 2010
EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer
April F Eichler, Kristopher T Kahle, Daphne L Wang, et al.
The Journal of Biological Chemistry
|
March 22, 2001
Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities
F Galbiati, J A Engelman, D Volonte, et al.
Cancer Research
|
December 3, 2005
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells
Steven J Isakoff, Jeffrey A Engelman, Hanna Y Irie, et al.
Cancer Research
|
May 19, 2011
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis
Ryan B Corcoran, Gianmarco Contino, Vikram Deshpande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2009
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
David Jackman, William Pao, Gregory J Riely, et al.
Nature Reviews. Cancer
|
March 25, 2017
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals, Scott Cameron, Daniela Cipolletta, et al.
Oncotarget
|
February 21, 2020
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
Hengyu Lu, Chen Liu, Hung Huynh, et al.
Page
of 24
Search research articles
Search
Showing results (91-100 of 238) with videos related to
Sort By:
Page
of 24
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2005
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
Jeffrey A Engelman, Pasi A Jänne, Craig Mermel, et al.
Pathologica
|
September 1, 1993
[The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]
E Philippe, B Faguer, A Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 17, 2012
FGFR1 amplification in squamous cell carcinoma of the lung
Rebecca S Heist, Mari Mino-Kenudson, Lecia V Sequist, et al.
Neuro-Oncology
|
July 15, 2010
EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer
April F Eichler, Kristopher T Kahle, Daphne L Wang, et al.
The Journal of Biological Chemistry
|
March 22, 2001
Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities
F Galbiati, J A Engelman, D Volonte, et al.
Cancer Research
|
December 3, 2005
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells
Steven J Isakoff, Jeffrey A Engelman, Hanna Y Irie, et al.
Cancer Research
|
May 19, 2011
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis
Ryan B Corcoran, Gianmarco Contino, Vikram Deshpande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2009
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
David Jackman, William Pao, Gregory J Riely, et al.
Nature Reviews. Cancer
|
March 25, 2017
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals, Scott Cameron, Daniela Cipolletta, et al.
Oncotarget
|
February 21, 2020
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
Hengyu Lu, Chen Liu, Hung Huynh, et al.
Page
of 24